Meropenem-Induced Facial Myoclonus.

Millar Vernetti, Patricio; Dalamo, Kaia; Khan, Zenith; Gonzalez-Duarte, Alejandra; Frucht, Steven; Kaufmann, Horacio

Millar Vernetti, Patricio; Dalamo, Kaia; Khan, Zenith; Gonzalez-Duarte, Alejandra; Frucht, Steven; Kaufmann, Horacio.

Affiliation

Millar Vernetti P; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Dalamo K; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Khan Z; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Gonzalez-Duarte A; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.
Frucht S; Department of Neurology Fresco Institute for Parkinson's and Movement Disorders New York University Grossman School of Medicine New York New York USA.
Kaufmann H; Department of Neurology, Dysautonomia Center New York University School of Medicine New York New York USA.

Mov Disord Clin Pract ; 10(Suppl 3): S21-S23, 2023 Aug.

Article de En | MEDLINE | ID: mdl-37636233

Mots clés

carbapenems; myoclonus; neurotoxicity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Mov Disord Clin Pract Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google